Ascend

Ascend Advanced Therapies is a UK-based gene therapy CDMO founded to address the need for quality manufacturing capacity for gene and cell therapy developers globally. The company’s core expertise is in GMP production of adeno-associated virus (AAV) vectors. Leveraging patented split two plasmid technology, the platform drives high product yield, potency, and improved quality across serotypes. This is underpinned by a powerful analytical toolkit with a suite of proprietary assays supporting formulation development.